Geernaert, M. A.

mupirocin aureus patient bacteraemia mupirocin prophylaxis aureus bacteraemia haemodialysi incidence prophylaxi infection study patient-year haemodialysis patients carriage month staphylococcus 6 months dialysis carrier boelaert staphylococcus aureus period treatment mupirocin resistance study periods ointment calcium culture analysis episode staphylococcus aureus bacteraemia 106 patients staphylococcus aureus infections maintenance haemodialysis aureu ~ bacteraemia population maintenance trial resistance catheter development haemodialysis population 44.1 patient-years characteristic venous catheter eradication pre-mupirocin era mupirocin application haemodialysis unit result 43 patient-years aureu mupirocin use iron overload table i aureu ~ diabetes mellitus b 8000 bruges diabetes fisher blood uureus bacteraemia 4*26- application 6 months study hemodialysi haemodialysis patients increases follow-up pre-mupirocin baere haemodialysis 45 incidence contingency table analysis patients <65 years haemodialysis 43 results absence table aureus mupirocin bacteraemia aureus bacteraemia patient-year van landuyt hw bacteraemiasin haemodialysis patients mellitu